Thiamin (Vitamin B1) Levels in Eating Disorder Adolescent Patients
NCT02164487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69
Last updated 2020-05-27
Summary
Vitamin B1 (Thiamine) is a water soluble essential nutrient; it is synthesized by a variety of plants and microorganisms. Since animals usually cannot synthesis it, humans must be supplied with exogenous vitamin B1 in the diet. The human storage of thiamine is small- about 30mg, an intake of 1-2 mg a day is needed to maintain this pool. Deficiency might occur when the vitamin is depleted from the diet in a short period. Vitamin B1 has a role in energy metabolism and main biosynthetic pathways. Low thiamine causes illnesses in the central and peripheral nervous systems as well as affecting the heart and gastrointestinal systems.
Deficiency may occur from malnutrition of different mechanisms such as alcoholism, lack in diet and recently secondary to anti-obesity surgery and few case reports described eating disorders as the reason for developing deficiency causing neuropathy, (1,2) and encephalopathy (3,4,5).
One of the presentations of thiamine deficiency is peripheral neuropathy mimicking Guillain-Barre syndrome, and administering the lacking vitamin improves the symptoms.
One study examined the prevalence of vitamin B1 deficiency in adult anorexia nervosa patients (6) by measurement of the activation of the enzyme erythrocyte transketolase following addition of thiamin pyrophosphate and comparing them to control of blood donors. This study found significant lower levels of vitamin B1 in the anorectic patient compared to the controls.
Rational of the study:
The investigators assume that these few cases described of overt neurologic impairment due to vitamin B1 deficiency because of distorted eating are just the "tip of the iceberg" and more eating disorders patients lack thiamine, that may have neuropsychiatric effect on the illness and identifying and treating the shortage may improve the symptoms of the disorder and maybe even the distorted thoughts that are fundamental in eating disorders.
Conditions
Sponsors & Collaborators
-
Assaf-Harofeh Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 12 Years
- Max Age
- 19 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-01-31
Countries
- Israel
More Related Trials
-
A Randomised Controlled Trial on the Networks Integrating Anxiety and Metabolism in Anorexia Nervosa
NCT06814002 ·Status: RECRUITING ·Phase: NA
-
Studies of Neuroendocrine and Energy Metabolism in Patients With Eating Disorders
NCT00631605 ·Status: COMPLETED
-
Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa
NCT04878627 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Avoidant and Restrictive Food Intake Disorders (ARFID) in Adolescence: Early Oral Development, Psychopathological Profile and Sensory Integration
NCT06665802 ·Status: COMPLETED
-
The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders
NCT05865288 ·Status: UNKNOWN ·Phase: PHASE1
-
Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
NCT04128683 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ketogenic Diet and Brain Response in Anorexia Nervosa
NCT06540703 ·Status: RECRUITING ·Phase: NA
-
Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls
NCT02179814 ·Status: SUSPENDED ·Phase: NA
-
The Effects of Nutritional Intervention in Participants With Eating Disorders.
NCT06230107 ·Status: COMPLETED ·Phase: NA
-
Ketamine Effects on Learning In Eating Disorders
NCT06736769 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Drugs Experience for Adolescents With Anorexia
NCT06211517 ·Status: RECRUITING
-
Food Energy Density in Eating Disorders
NCT01095107 ·Status: WITHDRAWN ·Phase: NA
-
Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes
NCT05399446 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Smartphone-based Aftercare for Inpatients With Anorexia Nervosa
NCT04228939 ·Status: UNKNOWN ·Phase: NA
-
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
NCT07169747 ·Status: RECRUITING ·Phase: PHASE2
-
Reward Systems and Food Avoidance in Eating Disorders
NCT02795455 ·Status: COMPLETED ·Phase: NA
-
Treatment of Anxiety and Anorexia Nervosa in Adolescents
NCT01933243 ·Status: COMPLETED ·Phase: PHASE2
-
Lung Function Tests in Adolescents With Anorexia Nervosa
NCT00942929 ·Status: UNKNOWN
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
NCT06000774 ·Status: RECRUITING ·Phase: NA
-
Modified Ketogenic Diet and Ketamine for Anorexia Nervosa
NCT04714541 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Lesions in Patients With Eating Disorders
NCT05809778 ·Status: RECRUITING
-
Hunger and Satiety in Anorexia Nervosa
NCT02932046 ·Status: COMPLETED
-
Emotional Dysregulation, Maladaptive Overcontrol in Anorexia - Effect of Radically Open Dialectical Behaviour Therapy
NCT06244576 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder
NCT00606411 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
NCT01038128 ·Status: COMPLETED ·Phase: NA